<DOC>
	<DOCNO>NCT01249560</DOCNO>
	<brief_summary>The objective antiretroviral treatment inhibit viral replication , estimate ( appreciate ) measure viral plasmatic load ( responsibility ) . In inhibition viral replication usually join immune reconstruction [ 1 ] . Nevertheless , viro-immunological dissociation , i.e . undetectable viral load ( responsibility ) absence immune reconstruction , regularly observe . It turn undetectable viral load ( responsibility ) correspond total absence viral replication possible detect intracellular pro-viral DNA . Raltegravir ® , mode action ( share ) inhibit integration pro-viral DNA chromosome infected cell ( unit ) , could decrease intracellular reservoir monocyte-macrophages , improve homeostasis , optimize cooperation lymphocytes T - macrophage . Several experimental data suggest regression abnormality cellular interaction , rate apoptose abnormally raise ( abnormally bring ) cell ( unit ) T patient viro-immunological dissociation , could obtain . This study aim measure impact Raltegravir ® viral reservoir lymphocyte monocyte , quantify expression molecule costimulation , source ( spring ) intercellular interaction lymphocytes - monocyte , measure rate apoptose cell ( unit ) T .</brief_summary>
	<brief_title>Impact Raltegravir Viral Reservoirs</brief_title>
	<detailed_description>20 patient include followed period 12 month Population essay Criteria inclusion : Patients 18 year 60 year HIV + treat ( handle ) : - Patients present undetectable viral load ( responsibility ) least 6 month year , use tritherapy contain 2 NUC + 1 IP . - Patients present immunosuppression `` average '' rate T CD4 understand 350 500 cell ( unit ) ml . - Patients know perfect observance . Criteria inclusion : - Preliminary Use inhibitor integrase - Patients present opportunist infection and\or evolutionary cancer - Patients benefit treatment IL-2 , interferon-alpha , steroids medicine know modify immunity . - Pregnant Women</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Patients 18 year 60 year HIV + treat ( handle ) : Patients present undetectable viral load ( responsibility ) least 6 month year , use tritherapy contain 2 NUC + 1 IP . Patients present immunosuppression `` average '' rate T CD4 understand 350 500 cell ( unit ) ml . Patients know perfect observance . Preliminary Use inhibitor integrase Patients present opportunist infection and\or evolutionary cancer Patients benefit treatment IL2 , interferonalpha , steroids medicine know modify immunity . Pregnant Women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>